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Abstract
Proton nuclear magnetic resonance (1H NMR) is a spectroscopic technique usually used
for structural  determination of  molecules.  In recent years,  this  technique has been
employed for easy and quick recognition of microorganisms, in antimicrobial suscept‐
ibility tests and even for the diagnosis of different infectious conditions. Though 1H
NMR shows great potential for expanded applications in microbiological studies, to
date applications of proton NMR to microbiological research are not totally standar‐
dized. In this chapter, we summarize the state of knowledge about 1H NMR and its
current and potential applications in this field.
Keywords: nuclear magnetic resonance, 1H NMR, applications, clinical microbiology,
microorganisms
1. Introduction
Scientific progress made in the recent years has enabled the development of new techniques
that facilitate and improve microbiological study. In this way, nuclear magnetic resonance
(NMR) is a spectroscopic technique easy to use and quick to recognize microorganisms and
provides sensitivity to antimicrobials. Anyway, to date we have not consensus about the
usefulness of these techniques that are not totally standardized. In this chapter, we summarize
the state of knowledge about NMR in microbiological studies.
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2. Nuclear magnetic resonance (NMR) spectroscopy
NMR is a spectroscopic technique initially developed by Felix Bloch and Edward M. Purcell
that relies on the magnetic properties of the atomic nucleus. Since 1946, it has become a
powerful and extremely valuable tool for chemists, physicists, biochemists and more recently
for the medical practitioners [1–5].
Although the most widespread application of NMR is the structural determination of mole‐
cules, the technique offers the advantage of direct mixture analysis, and therefore, NMR has
demonstrated a unique potential to be used for metabolic mixture analysis, fastidious bacteria
included [6]. In comparison with other techniques employed for mixture analysis, NMR can
be used to directly investigate biological samples and cell cultures without requiring signifi‐
cant sample preparation. Moreover, the technique allows the determination of compound
ratios in a highly reproducible manner. For these reasons, metabolomics and metabonomics
are driving new technological advances in the NMR field. Thus, the combination of sophisti‐
cated NMR‐based methods for mixture analysis with the power of statistical and chemometric
methods makes NMR spectroscopy the technique of choice for complex biological mixture
analysis, especially in clinical and biomedical researches [3, 4].
In the biological field, the NMR technique [7] is employed to determine the structure and
function of macromolecules. Additionally, NMR allows the determination of metabolic
changes in organisms in response to external stimuli, through the identification and quantifi‐
cation of metabolites (metabolomics/metabonomics). Metabolomics is the study of global
metabolite profiles of a cell under a given set of conditions; however, the terms metabolomics
and metabonomics are used in the literature interchangeably [8]. Jeremy Nicholson was the
pioneer of the approach, ‘the distinction between the two terms metabolomics/metabonomics
is mainly philosophical rather than technical’ [9].
Since NMR is the only technique that allows to carry out in vivo analysis, it has applications in
medical diagnosis, for example, magnetic resonance tomography (MRT).
The use of NMR in metabolic studies was reported in 1977, by Brown et al., who determined
the presence of lactate, pyruvate, creatinine, and alanine in a blood cell suspension by proton
NMR (1H NMR) [10]. Since then, the analysis of biological fluids, tissues, and cell extracts has
been carried out successfully by NMR, especially in the context of research on diseases and
evaluation of toxicological processes [11, 12].
2.1. Basics of NMR spectroscopy
The NMR phenomenon can only be carefully described and fully understood using quantum
mechanics. Therefore, a complete understanding of the technique would require an exhaustive
knowledge of the properties of the angular momentum in the quantum mechanics field, along
with statistical thermodynamics knowledge to describe the floating processes needed in the
liquid state.
However, since the theory and fundamentals of NMR have been fully developed over the last
few years [13, 14] and its detailed description would get away from the objective of this chapter,
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we describe below some aspects of the technique, which could help to understand the
equipment and methodologies used in metabolic research.
The basis of the technique is to use the magnetic properties of atomic nuclei that are defined
by their angular momentum and their associated magnetic moment. Both moments are vector
quantities, and they are related by a constant called gyromagnetic constant (γ), which is specific
to each type of atomic nucleus. According to quantum mechanics, both moments are quantized
and their value depends on a quantum number called spin (I). Not all nuclei are valid to get
NMR signals, only those whose spins are greater than zero are valid, but 1H or proton is the
most used nucleus in NMR studies. Moreover, higher the value of constant γ, more sensitive
will be the active nucleus in NMR. So, 1H is the nucleus used in NMR studies because of its
great abundance (100%) and high value of γ. However, other magnetically active nuclei with
lower sensitivity may be used, such as 2H (or D), 13C, 19F, 15N, 31P, and 23Na. Focusing on the
proton, in the presence of an external magnetic field (B0), two different energy levels appear.
The magnetic moments of these nuclei try to align with B0, resulting in two possible orienta‐
tions at that time. Each of these orientations corresponds to a different energy level. That is, in
the presence of B0, the cores can be arranged in two new states with different energies. This
phenomenon, from a vectorial viewpoint is known as magnetization.
To obtain a NMR signal, the sample is irradiated with a radiofrequency wave, perpendicular
to B0, which compels it to reach the state of resonance, where the nuclei gyrate with a resonance
frequency (f0), specific to each atomic nucleus and called Larmor frequency. For this reason,
NMR spectrometers are designated by the 1H resonance frequency instead of the magnetic
field (for example, on a 14.1 T field, 1H resonates at 600 MHz). After the pulse, the excited nuclei
return to the initial equilibrium state emitting a radiofrequency signal, which decays with the
time, a phenomenon known as relaxation. The resonance of the excited nuclear magnets is
detected as an oscillating current in a coil placed around the sample. This signal is the FID (free
induction decay), which arrives at the receiver and provides a spectrum formed by lines
defining frequencies and widths by a mathematical operation known as Fourier transform.
The widths are formed from the contributions of all nuclei of the sample, so that this quality
allows quantitative measurements. A line in the NMR spectrum obtained at a certain frequency
(or chemical shift) corresponds to an atomic nucleus with a given chemical environment, which
allows structural information about the molecule it belongs.
2.2. Equipment
The NMR spectrometer involves several parts such as a superconducting magnet, a radio
transmitter, a probe, a radio receiver, an analog‐to‐digital converter (ADC), and finally, a
computer. The magnet is the main element and consists of a solenoid of superconducting Nb/
Ti alloy wire immersed in liquid helium (4 K) that is charged to generate the essential field
strength. The helium is protected with a vacuum jacket and further cooled by an outer dewar
of liquid nitrogen (77 K).
The probe head is a coil of wire positioned around the sample (NMR tube) that alternately
transmits and receives radio frequency signals. The probe head is usually hosted into the
magnet from the bottom and is connected to at least three radiofrequency channels provid‐
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ing the 2H lock, 1H frequency, and one X‐nucleus frequency. In general, devices to control
temperature (heater, thermoelement, and air) are needed. New developments include the
digital transmission of the probe‐head parameters to the console.
The computer addresses the transmitter to send a high‐power and very short duration pulse
of radio frequency to the probe‐head. Instantly, after the pulse of radio frequency, a weak signal
(FID) from the sample received by the probe‐head is amplified and sampled at intervals by the
ADC to produce a digital FID signal, which is just a list of numbers. The computer automati‐
cally determines the timing and power of pulses output by the transmitter and receives and
processes the digitalization. After the computer performs the mathematical processes of
Fourier transform in order to convert time domain into frequency domain, the resulting
spectrum can be displayed on the computer monitor, transferred to other computers or plotted
on a paper.
2.3. Sample preparation
The sample volume should be about 0.6 mL, which gives a 4.0 cm depth in a standard 5 mm
NMR tube. Volume of the samples is less important than the concentration of targets. Very
small volumes could not be studied by NMR equipment with low magnetic field but once the
volume is established, it is more important to ensure that the metabolites to be studied are in
Figure 1. Components of an NMR equipment.
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an appropriate concentration. For biological samples, the ideal solvent is D2O or a mixture of
H2O/D2O. In this latter case, the 1H NMR spectra will be recorded using the pulse sequence for
presaturation or the equivalent in order to avoid the signals from water. This is the typical and
most simple method used to record NMR spectra of biological samples.
Usually, the protocol of preparation for biological and aqueous samples is simple, quick and
involves two steps. Samples are prepared from inocula of the microorganisms and the bacterial
concentration is adjusted using 0.5–2 McFarland standards [15, 16]. Cultures are incubated at
the optimum temperature and time to preserve the same growth conditions than the reference
method, if possible. After incubation, the suspensions are removed by centrifugation and the
supernatants are decanted and used for NMR experiments. Because the measurements are
carried out on supernatants, there is no need to quench cell growth rapidly. Furthermore, pH
is measured and fixed by the slow addition of aqueous 1 M HCl and 1 M NaOH solutions or
with a buffer solution in order to fix the chemical shifts. Next, a biological sample is added to
a 5 mm NMR tube together with D2O with the addition of the sodium salt (trimethyl)propa‐
noic‐2,2,3,3‐d4 acid (TSP) for the chemical shift calibration. Figure 1 shows an overview of the
components of NMR equipment.
2.4. Sample treatment
The quality of the obtained NMR spectra depends on several variables that influence the
process from sample collection to final data collection. The sample collection involves the
sample, containers used, additives (preservatives, stabilizers), and time (collection, transport,
storage) [17].
Depending of the source of the biological sample, two different methodologies can be used for
the experiment acquisition:
(A) Sample concentration by lyophilization and subsequent reconstitution with a deuterated
solvent: using this methodology, NMR experiments can be performed without solvent
suppression, allowing an increase in sensitivity and stopping enzyme activity. The risks in
using this method include the possibility of introducing contaminants into the sample and
more importantly, the loss of volatile compounds.
(B) The addition of a small amount of D2O to the aqueous sample: the corresponding NMR
experiment is performed with a pulse program that can remove the water signal, which would
otherwise mask the signals from the rest of the sample. This method involves minimal sample
handling and the ability to detect volatile compounds, making it a more suitable method for
metabolite analysis of biological samples.
In addition to these processes, due to the infectious potential of microorganisms contained in
the sample, all steps of sample processing must be performed safely, through protocols and in
laboratories appropriate to the biosafety level for the organism—until the organism is
inactivated.
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2.5. Data processing
Interpretation of the NMR data is essential to complete metabonomics studies to draw
conclusions and trends. The first thing is to perform a pre‐processing of NMR data in which
NMR spectra are cleaned up in standard ways. After treatment of the spectra, it is possible to
get information of metabolites, either through direct quantification by parameters [18, 19] or
by applying the methods of data analysis and modelling. In this case, chemometric techniques
and multivariate analysis are used to identify and quantify the different metabolites present
in the sample. Figure 2 shows an example of NMR spectrum with the main metabolites
obtained. The existence of NMR databases of metabolites can greatly facilitate the latter
processes.
Figure 2. 1H NMR spectrum showing the main metabolites.
3. Applications of 1H NMR spectroscopy in clinical microbiology
The application of 1H NMR to living cells is used to determine metabolites in complex mixtures
and has been widely used for identification and quantification of the bacterial species [15, 20].
This technique has also been applied for antimicrobial drug susceptibility studies on different
species of yeast, and in the last few years, it has also been developed for bacterial studies.
Furthermore, other determinations directly in body fluids have emerged to help in the
diagnosis of different diseases and conditions.
3.1. Bacterial identification and metabolic studies
1H NMR spectroscopy has been used for bacterial identification and quantification and for
metabolic pathways studies. Several studies have been conducted for the diagnosis of the
bacteria that cause urinary tract infections (UTI). These focus on the use of 1H NMR spectro‐
scopy for the identification and quantification of common uropathogens such as Pseudomonas
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aeruginosa, Klebsiella pneumoniae, Escherichia coli, and Proteus mirabilis in urine samples. These
studies are based on specific properties of the metabolism of the studied bacteria, and the
results showed that 1H NMR is a simple and fast tool compared with the traditional methods
[16, 21, 22].
The qualitative and quantitative determination of P. aeruginosa using NMR spectroscopy is
based on the specific property of the bacteria to metabolize nicotinic acid (NA) to 6‐hydroxy‐
nicotinic acid (6‐OHNA). Only this bacterium can produce this reaction. The addition of NA
to urine samples after incubation and the subsequent analysis by 1H NMR spectroscopy
showed that NA signals disappeared from the medium after some time, while the appearance
of new signals of the metabolite 6‐OHNA indicated the presence of P. aeruginosa. The increase
in the intensity of the metabolite signals, together with the decrease in the NA signals, involved
a proportional increase in the number of bacteria. This shows the potential offered by this
technique for quantitative and qualitative identification, simultaneously, on the bacteria [21].
A similar process occurs in the determination of K. pneumoniae. In this case, the specific
metabolic reaction is the transformation of glycerol into 1,3‐propanediol, so the substance that
is added into the medium is glycerol. Despite Citrobacter freundii also being capable of carrying
out this reaction, both bacteria can be easily differentiated using microscopic examination by
observing their motility. K. pneumoniae is not mobile while C. freundii is. In addition, C. freundii
is not a common nosocomial urinary tract infection agent. The combination of both methods
showed very good sensitivity and specificity (90 and 100%, respectively), suggesting the
potential usefulness of NMR for bacterial diagnosis [22].
The same experiment carried out on E. coli and P. mirabilis revealed that the specific metabolites
of the bacteria are lactate and 2‐hydroxy‐4‐(methylthio)butyric acid (MOBA) after incubation
with lactose and methionine, respectively [16].
The results obtained using this alternative technique provided the warrant for the development
of this method in bacterial identification and quantification and the technical development
with other microorganisms. With experience, spectral analysis and data interpretation could
be quick and reliable [16].
3.2. Antimicrobial susceptibility assays
The use of 1H NMR spectroscopy for antimicrobial susceptibly tests has been not highly studied
despite its powerful utility in this area of study [5]. Application of 1H NMR spectroscopy to
antimicrobial susceptibility studies was first carried out on different species of yeast. The
standardized methods currently available for fungal susceptibility studies are unreliable and
relatively slow, so, 1H NMR spectroscopy can be a simple indicator, an objective and fast
method (metabolic changes detected by this method are more easily observed than growth
inhibition in broth). 1H NMR spectroscopy is potentially valuable in determining the metabolic
composition of yeast suspensions incubated with a drug. In addition, it is a high performance
automated method with low operating costs, so that both operator time and reagent cost are
greatly reduced. Therefore, it has great potential to emerge as an alternative method for the
antifungal drug susceptibility determination of different yeast species [15, 20].
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One of the few studies in which the 1H NMR technique has been applied to observe the effect
on microorganisms upon exposure to several drugs, has been carried out with medically
relevant fungi. The fungal species analysed were Cryptococcus neoformans, different species of
Candida and Aspergillus spp. These studies are based on the identification of the fungal
metabolites produced, on their comparative profile implementation and on the monitoring of
the nutrient utilization of the incubation medium in the presence of certain drug concentrations
(caspofungin, amphotericin B, and voriconazole). The spectra obtained after subjecting the
sample to the 1H NMR were interpreted based on the metabolites produced (fumarate, malate,
ethanol, etc.) and/or the metabolites consumed (tyrosine, phenylalanine, valine, etc.). This
interpretation established a measurable parameter, the metabolic end point (MEP), from the
spectral peak area. The MEP is defined as the lowest drug concentration at which nutrient
utilization from the medium or the production of fungal metabolites is inhibited ≥ 50% and
compared with minimum inhibitory concentrations (MIC) used in the reference method. The
results of MEP generally showed a good correlation with MICs, which were determined by a
modification of the reference method in broth microdilution M27‐A of the CLSI. Discrepancies,
which may arise between MEPs and MICs, could be due to differences in the culture medium
and incubation time. In addition, 1H NMR spectroscopy is a potentially valuable method for
determining the metabolism of microorganisms incubated with the drug because it is a
reproducible and relatively quick method (it takes 16 h versus 48 h required by the reference
method) suggesting its consolidation as a platform for rapid determination of antifungal
susceptibility [15, 20].
In reference to bacteria, there are very few studies based on their antimicrobial susceptibility
according to metabolic profiling by 1H NMR. One of these studies focused on a bacterial disease
called ‘Withering Syndrome’ of abalone (a type of mollusc belonging to Haliotis spp. important
in aquaculture). It is caused by a pathogen of the Rickettsiaceae family, ‘Candidatus Xenohaliotis
californiensis’ that infects digestive epithelial cells [23, 24]. On this basis, the effects of the
antibiotic oxytetracycline in the metabolic profiles were observed by 1H NMR. This drug, used
to treat bacterial infections in aquatic species, reduces the severity and mortality of the
Withering Syndrome. The aim of this study was to observe whether the recovery of the
metabolism during treatment with oxytetracycline coincided with the disappearance of the
disease caused by the bacteria. To this end, they examined the metabolic constituents present
in the foot muscle of the mollusc after oxytetracycline treatment during several established
days at two different seawater temperatures (13.4 and 17.3°C) [24]. Metabolic changes were
observed at both temperatures: levels of taurine, glycine‐betaine, and homarine increased and
the amino acid and carbohydrate levels decreased. The detection of metabolic differences
between animals treated and untreated with antibiotics was observed only at the highest
temperature. Therefore, oxytetracycline eradicated the infection and at the highest tempera‐
ture it reduced the metabolic changes due to the syndrome. The conclusions drawn from these
experiments drive the development of 1H NMR based on metabolic studies and its comple‐
mentarity with other techniques, such as the histology for the identification of pathological
processes in the aquatic species and for the optimization of drug therapy. This tool displays
the performance by analysing quickly and cheaply the functional status of an organism [23, 24].
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We have analysed the metabolism and antimicrobial susceptibility of Escherichia coli ATCC
25922 in the presence of gentamicin using 1H NMR and compared with a reference method
[25]. The MIC, determined by the reference method used in this study, would correspond to
the termination of the bacterial metabolism observed using NMR. To carry out these experi‐
ments, serial dilutions of gentamicin were tested. Furthermore, two controls were also
analysed (one was the medium with an inoculum of bacterium (control I), and the other was
only the medium (control II)). The comparison of the two control 1H NMR spectra showed
different signals. Succinic acid, acetic acid, and ethanol were only detected in the control I
spectra and threonine was only detected in the control II medium. According to the results
obtained by visual turbidity, the lowest concentration of drug that completely inhibited visible
growth (MIC) was 0.5 μg/ml (MIC: 0.25–1 μg/ml) [26]. When we registered antibiotic spectra
at different concentrations, we detected the presence of succinic acid, acetic acid, and ethanol
only in samples with concentrations of gentamicin lower than the MIC. Moreover, when the
concentration of gentamicin was greater than the MIC, we detected the presence of threonine.
These data suggested that the results obtained by 1H NMR spectroscopy were in agreement
with those obtained by visual turbidity. These results confirm that E. coli is able to metabolize
components of the medium to produce succinic acid, acetic acid, and ethanol. Furthermore,
threonine only appeared in the spectra of those samples with gentamicin concentrations of
≥0.5 μg/ml. Differences in peak intensities for the metabolites observed in spectra allowed the
determination of the MIC for gentamicin using 1H NMR spectroscopy. Consumption of the
amino acid threonine, present in the culture medium, was interrupted when MIC was
performed. Therefore, we assume that succinic acid, acetic acid, and ethanol are metabolites
produced by the bacteria and threonine is the amino acid consumed by E. coli.
Furthermore, to evaluate the potential of this tool, we also performed the same biological
experiments but using an NMR tube as the incubation reactor. The bacterial activity occurred
effectively within the NMR tube, and the metabolic process started around 3 h 20 min and
ended at 6 h. Moreover, when samples containing gentamicin were analysed in the same way
the ethanol signal appeared later using the lowest concentration of gentamicin (4 h 40 min)
compared with the experiments performed in the absence of the antibiotic (3 h 20 min) and
much later (8 h 40 min) when the gentamicin concentration used was close to MIC. Similarly,
threonine consumption by bacteria was delayed when the concentration of antibiotic in the
medium was higher [25].
3.3. Applications in biofluids
In the last few years, 1H NMR has been used to directly analyse biofluids and to diagnose
different diseases directly from body fluids. In this sense, it has been applied to analyse human
microbiota from faeces and urine samples, to study the metabolic implications that take place
in sepsis, or even to diagnose hepatitis C virus infection, distinguish HIV‐1 positive patients
from negative individuals or to diagnose pneumonia from urine [27–33].
As mentioned above, 1H NMR has been employed to study gut microbiome focusing on the
metabolite profiling obtained by the analysis of different human samples. In this sense, Jacobs
et al. [27] studied faeces from healthy subjects after consuming placebo, grape juice, or a mix
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of grape juice and wine during four weeks by 1H NMR. The comparison of the NMR profiling
of the samples indicated that only the mixture of wine and grape juice was able to modulate
gut microbiota assessed by the reduction in isobutyrate observed only in the samples from
subjects who had consumed the mixture. These results confirm that 1H NMR could determine
the impact of the nutrition in human microbiome [27]. Furthermore, the use of 1H NMR to
understand gut microbiota has been also extended to the study its impact on obesity by
analysing metabolite profiling obtained from urine samples [28, 34].
1H NMR has been also used to study different conditions as sepsis. Stringer et al. used 1H NMR
to compare the metabolic profile of whole blood from serum. This study revealed that the use
of 1H NMR in whole blood allowed obtaining more metabolic details that serum, and, in some
cases, the metabolites detected were in higher concentrations in whole blood than in serum.
Furthermore, whole blood allowed the determination of metabolites associated with red blood
cell metabolism and observed that alterations in their metabolism could be in relationship with
sepsis due to the haemolysis they cause [29]. The same authors have carried out several
experiments in the same way. In these experiments, they were able to observe that blood
samples of sepsis‐induced acute lung injury patients were measurable and distinguishable
from healthy blood due to differences in metabolites using 1H NMR [35]. Other studies have
been carried out to evaluate sepsis by 1H NMR, but in rats [30]. Metabolic profiles obtain from
the 1H NMR analysis reveal changes in the metabolites involved in energy metabolism,
especially in the serum of septic rats. From these results, authors concluded that according to
the metabonomic approach, 1H NMR has the potential for the early prognostic evaluation of
sepsis [30].
As discussed above, 1H NMR has been applied to the diagnosis of hepatitis C virus infection
[31]. This study performed in urine samples was able to identify infected patients and negative
individuals with good sensitivity and specificity using a metabonomics model based on the
spectra obtained from the urine samples analysis. In this study, although the differences
observed in the spectra allowed comparison of both groups, the chemical structures showed
in the spectra are still being analysed [31]. In a similar way, 1H NMR has been also used to
distinguish between HIV‐1 positive/AIDS patients on antiretroviral treatment and HIV‐1
negative individuals [32]. These experiments were carried out in serum samples and differ‐
ences in the metabolite profiling showed the distinction between the two groups. The authors
also suggested that ARV‐associated side effects could be monitored using 1H NMR [32].
Pneumococcal pneumonia is another condition that has been diagnosed using 1H NMR [33].
The use of the technique applied to urine samples of patients diagnosed with pneumonia has
enable to distinguish pneumonia caused by Streptococcus pneumoniae from that caused by other
microbes such as viruses or other bacteria. This distinction is observed due to the differences
in the metabolomic profiles. So the use of 1H NMR‐metabolite profiling could result in a rapid,
specific and sensitive tool for the diagnosis of pneumococcal pneumonia. In this study, it is
also observed that the metabolic profile shown in the samples of patients with pneumonia
caused by S. pneumoniae changed to a more normal metabolite profiling when specific
treatment is administrated, suggesting that the urinary profiles were specific to the infection
[33].
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3.4. Other types of analyses
The combination of NMR spectroscopy, with the use of isotopically substituted molecules as
tracers is a well‐established protocol in microbiology. These NMR analyses appear to be the
most appropriate for such studies because of their analytical power (provided that the labelling
of products can be easily monitored non‐invasively), their non‐destructive features, and the
large number of compounds that can be analysed simultaneously [6, 36–40]. However, despite
the great potential of this combination in clinical practice, these analyses are out of the aim of
this chapter.
4. Conclusion
In conclusion, 1H NMR is an emerging technique in the microbiological field that promises to
be a useful tool for the diagnosis of a broad range of conditions, including rapid identification
of microorganisms, antimicrobial susceptibility and infectious‐related syndromes. It can be
also employed for knowing the metabolic pathways used by microorganisms, allowing the
performance strategies for fighting against the infection.
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